ESR1 and breast carcinoma: Previously unrecognized as a hub, SLC39A6 functions as a zinc transporter, and was identified in [59] to be highly expressed in ESR1-positive tumors as well as showing a highly significant association with the spread of breast cancer to the lymph nodes.